Portfolio Company · Operating Co.

Vivere Oncotherapies

Not on record

backed byPillar VC

Current

a portfolio company of

Pillar VC

Status on record: Current

Investment year: 2022

PE Firm Index

Who owns Vivere Oncotherapies?

Vivere Oncotherapies is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Vivere Oncotherapies since 2022, per Pillar VC's portfolio page.

Company Snapshot

Vivere Oncotherapies' owner on record, Pillar VC, is a firm. Pillar VC lists at least 78 companies in the index.

SectorNot on record

Parent PE firmPillar VC

Ownership statusCurrent

WebsiteNot on record

About the owner

Pillar VC

Companies in the index: At least 78

Early-stage venture capital firm based in Boston.

Read the Pillar VC profile

Questions about Vivere Oncotherapies

Who owns Vivere Oncotherapies?

Vivere Oncotherapies is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Vivere Oncotherapies since 2022, per Pillar VC's portfolio page.

Sources

Pillar VC
https://www.pillar.vc/companies/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Vivere Oncotherapies and does not provide investment advice.

Other portfolio companies of Pillar VC

6 of 77 shown

Abridge

Advanced Computing, Healthcare

AceLab

Enterprise Intelligence

Decentralized Systems

Amber Bio

Medicines, Synthetic Biology

See the full Pillar VC portfolio.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Pillar VC

Status: Current

Investment year: 2022

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.